PHAIM PHARMA LTD

Active London

Research and experimental development on biotechnology

5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PHAIM PHARMA LTD

Research and experimental development on biotechnology

Founded 15 Dec 2014 Active London, England 5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

DMNOMORE LIMITED 15 Dec 2014 — 13 Mar 2020
Accounts Submitted 30 Jun 2025 Next due 31 Mar 2026 23 days overdue
Confirmation Submitted 11 Feb 2026 Next due 8 Dec 2026 7 months remaining
Net assets £-791K £14K 2024 year on year
Total assets £69K £72K 2024 year on year
Total Liabilities £861K £58K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

16 Great Queen Street London WC2B 5AH England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for PHAIM PHARMA LTD (09355572), an active life sciences and medical technology company based in London, England. Incorporated 15 Dec 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£98.00

Increased by £87.00 (+791%)

Net Assets

-£791.05k

Decreased by £14.35k (-2%)

Total Liabilities

£860.52k

Decreased by £58.04k (-6%)

Turnover

N/A

Employees

5

Decreased by 1 (-17%)

Debt Ratio

1239%

Increased by 591 (+91%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2020Seed

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 10,223 Shares £854k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Mar 202447£165k£4k
31 Mar 201895£95k£1k
28 Oct 2015585£585k£1k
16 Dec 20149,496£9k£1

Officers

Officers

2 active 1 resigned
Status
Broadway Secretaries LimitedCorporate-secretaryUnknownUnknown31 May 2017Active
Orban, Tihamer, DrDirectorHungarian,americanUnited Kingdom7415 Dec 2014Active

Shareholders

Shareholders (36)

Tihamer Orban
45.1%
4,814
Nara Timea Daubeney
14.8%
1,583

Persons with Significant Control

Persons with Significant Control (4)

4 Active

Prof Piers Edward Francis Daubeney

British

Active
Notified 6 Apr 2016
Residence England
DOB March 1964
Nature of Control
  • Significant Influence Or Control

Dr Nara Daubeney

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB February 1976
Nature of Control
  • Significant Influence Or Control

Hiam Orban Nee Jalahey

Hungarian

Active
Notified 6 Apr 2016
Residence England
DOB March 1948
Nature of Control
  • Significant Influence Or Control

Tihamer Orban

Hungarian

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB July 1951
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Group Structure

Group Structure

PHAIM PHARMA LTD Current Company
DAIM PHARMA LTD united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Feb 2026Confirmation StatementConfirmation statement made on 2025-11-24 with updates
10 Feb 2026CapitalAllotment of shares (GBP 10,671) on 2024-03-28
30 Jun 2025AccountsAnnual accounts made up to 2024-06-30
3 Dec 2024Confirmation StatementConfirmation statement made on 2024-11-24 with no updates
28 Jun 2024AccountsAnnual accounts made up to 2023-06-30
11 Feb 2026 Confirmation Statement

Confirmation statement made on 2025-11-24 with updates

10 Feb 2026 Capital

Allotment of shares (GBP 10,671) on 2024-03-28

30 Jun 2025 Accounts

Annual accounts made up to 2024-06-30

3 Dec 2024 Confirmation Statement

Confirmation statement made on 2024-11-24 with no updates

28 Jun 2024 Accounts

Annual accounts made up to 2023-06-30

Recent Activity

Latest Activity

Confirmation statement made on 2025-11-24 with updates

2 months ago on 11 Feb 2026

Allotment of shares (GBP 10,671) on 2024-03-28

2 months ago on 10 Feb 2026

Annual accounts made up to 2024-06-30

9 months ago on 30 Jun 2025

Confirmation statement made on 2024-11-24 with no updates

1 years ago on 3 Dec 2024

Annual accounts made up to 2023-06-30

1 years ago on 28 Jun 2024